June 2005: The Evolving Role of Anticoagulation in Coronary Intervention. 3rd Annual New Jersey Cardiovascular Symposium: An Update in the Management of Acute Coronary Syndromes and Heart Failure. Newark , NJ .

March 2005: Unfractionated Heparin Is Obsolete in the Cath Lab-Opening Arguments/Rebuttal, Protagonist. Debate at the ACC Annual Scientific Sessions, Orlando, FL.

September 2004: Monitoring of Low Molecular Weight Heparins - from Theory to Practice.  Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Sessions, Washington , DC . 

April 2004: Enoxaparin in Acute Coronary Syndromes and Percutaneous Coronary Intervention. Interventional Cardiology Review Course, San Jose , CA .

September 2003: The Emerging Role of Natriuretic Peptides in Percutaneous Coronary Intervention.  Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Sessions, Washington , DC . 

July 2003: Anticoagulant effects of LMWHs in surgical and interventional indications. Presented to the WHO Working Group on Unfractionated Heparin and Low Molecular Weight Heparin / Working Party on Monitoring of Low Molecular Weight Heparin. Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis, 49th Annual Meeting, Birmingham , UK

June 2003: Intravenous Low Molecular Weight Heparin During PCI.  Tenth International Symposium on Thromboembolism, London , England .

March 2003: Role and Controversies of Antithrombin Therapy in the Cardiac Catheterization Laboratory. 4th Annual Antithrombotic Therapy Symposium, Detroit , MI .

January 2003: Adjunct Pharmacology for PCI. Cardiovascular Revascularization Therapy 2003, Washington , DC .

Oct. 2002: Anti-inflammatory Effects of Anti-platelet Agents. Sixth Annual Scientific Meeting of the Insitute of Cardiovascular Science and Medicine, Hong Kong .

September 2002: Low Molecular Weight Heparins and Direct Thrombin Inhibitors. Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Sessions, Washington , DC .

June 2002: Monitoring Antithrombotic Therapy During Arterial Intervention. Ninth International Symposium on Thromboembolism, Seville , Spain . 

September 2001: GPIIb/IIIa Inhibitors- New Trial Insights and Controversies. Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Sessions, Washington , DC . 

July 2001: Direct Thrombin Inhibition in Percutaneous Coronary Intervention. Second International Congress on Heart Disease, Washington , DC .

June 2001: Monitoring Low Molecular Weight Heparins During Coronary Intervention. Eighth International Symposium on Thromboembolism, Florence , Italy .

May 2001: Challenges in the Modern Management of Complex Coronary and Peripheral Vascular Disease. Scripps Memorial Hospital , La Jolla , CA . 

March 2001: State of the Art Antithrombotic Therapy 2001.  LMWH in Interventional Cardiology. Wayne State University , Dearborn , MI . 

March 2001: Adenoviral-mediated Angiogenic Gene Therapy. Annual Scientific Sessions of the American College of Cardiology, Orlando , FL.

Nov. 2000: Low Molecular Weight Heparins in Coronary Intervention. Annual Scientific Sessions of the American Heart Association, New Orleans , LA.  

Oct. 2000: Oral Antiplatelet Agents. Interventional Cardiology Review Course, Transcatheter Cardiovascular Therapeutics (TCT) Annual Symposium , Washington , DC .

August 2000: Congress of the European Society of Cardiology. Differentiation of Glycoprotein IIb/IIIa Inhibitors. Amsterdam , The Netherlands . 

May 2000: Paris Course on Revascularization. Switching Patients from Small Molecules to Abciximab. Paris , France .  

March 2000: Alternative Revascularization Strategies: PMR/DMR and Angiogenesis.  Evening session panelist at the American College of Cardiology 49th Annual Scientific Sessions, Anahiem , CA .

Oct. 1999: Tirofiban in the Management of Acute Coronary Syndromes. Symposium on Platelet GP IIb/IIIa Inhibitors. Lisbon , Portugal .

Oct. 1999: Congress of the Korean Society of Circulation.  Platelets as the target in thrombus formation. Seoul , Korea .

Sept. 1999: Aspirin and Thienopyridines. Interventional Cardiology Review Course, Transcatheter Cardiovascular Therapeutics (TCT) Annual Symposium , Washington , DC .

Sept. 1999: Keynote Address: New Pharmacologic Adjuncts in Coronary Intervention. Cardiac Intervention in Chicagoland, Chicago , Illinois .

Sept. 1999: ACS Debate Club. Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Sessions, Washington , DC .

Sept. 1999: Platelet Receptor Inhibitors. Cardiology Grand Rounds, University of Virginia , Charlottesville , VA.

August 1999: Acute Myocardial Infarction: Invasive versus Medical Therapy. Invitational Cardiology Symposium, Akron General Medical Center , Akron , OH .

June 1999: Gene Therapy for Therapeutic Angiogenesis. A Live Symposium of Complex Coronary Cases. New York , NY .

April 1999: Platelet Glycoprotein IIb/IIIa Receptor Blockers in Coronary Interventions: What Did We Learn from EPIC, EPILOG, EPISTENT, RESTORE, and IMPACT II?  Boston , MA

March 1999: GPIIb/IIIa Inhibition in Acute Coronary Syndromes Management. CME Symposium at the 1999 Annual Meeting of the American College of Cardiology. New Orleans , LA.

Jan. 1999: Indications for GP IIb/IIIa Inhibitors in Acute Coronary Syndromes and Percutaneous Coronary Interventions. St. Louis University Hospital , St. Louis , MO.

Nov. 1998: New Paradigm in the Treatment of Acute Coronary Syndromes. The Role of Troponin and IIb/IIIa Inhibitor Therapy. Stony Brook University Hospital , NY .

Sept. 1998: Interventional Cardiology Update 98. CK versus Troponin in the Diagnosis of Acute Coronary Syndromes and Periprocedural CK Elevation. Orlando , FL.

Sept. 1998: The Bernard and Helen Perlman Lecture: Platelet GP IIb/IIIa Receptor Blockers. The New York Cardiological Society, Inc. 70th Anniversary Program on Emerging Issues in the Practice of Cardiology. New York , NY .

July 1998: Acute Coronary Syndromes: Incorporating New Therapies to an Established Algorithm of Care. Hartford , CT

June 1998: Gene Therapy for the Management of In-stent Restenosis. A Live Symposium of Complex Coronary Cases. New York , NY .

June 1998: Molecular Biology of Restenosis. Current Medical and Interventional Therapy in Acute Coronary Syndromes. New York , NY .

April 1990: The Acute Biological Response to Excimer Versus Thermal Laser Angioplasty in Experimental Atherosclerosis. Symposium on Laser Angioplasty. University Hospital Utrecht , Maastricht , The Netherlands .